Fulcrum Capital LLC Has $11.41 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Fulcrum Capital LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 16.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 22,561 shares of the healthcare conglomerate’s stock after buying an additional 3,202 shares during the period. UnitedHealth Group comprises about 2.4% of Fulcrum Capital LLC’s portfolio, making the stock its 11th biggest holding. Fulcrum Capital LLC’s holdings in UnitedHealth Group were worth $11,413,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in the company. JCIC Asset Management Inc. grew its holdings in shares of UnitedHealth Group by 2.3% during the 4th quarter. JCIC Asset Management Inc. now owns 11,654 shares of the healthcare conglomerate’s stock worth $5,895,000 after purchasing an additional 263 shares in the last quarter. Accelerate Investment Advisors LLC grew its stake in UnitedHealth Group by 65.8% during the fourth quarter. Accelerate Investment Advisors LLC now owns 809 shares of the healthcare conglomerate’s stock worth $409,000 after buying an additional 321 shares in the last quarter. Wedmont Private Capital lifted its holdings in shares of UnitedHealth Group by 4.1% during the 4th quarter. Wedmont Private Capital now owns 12,781 shares of the healthcare conglomerate’s stock worth $6,655,000 after acquiring an additional 501 shares during the period. Salem Investment Counselors Inc. raised its position in UnitedHealth Group by 1.9% during the fourth quarter. Salem Investment Counselors Inc. now owns 38,538 shares of the healthcare conglomerate’s stock valued at $19,495,000 after purchasing an additional 727 shares in the last quarter. Finally, Agate Pass Investment Management LLC boosted its holdings in shares of UnitedHealth Group by 8.3% in the 4th quarter. Agate Pass Investment Management LLC now owns 1,629 shares of the healthcare conglomerate’s stock valued at $824,000 after purchasing an additional 125 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Cantor Fitzgerald increased their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. Barclays upped their price target on shares of UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a report on Wednesday, November 27th. Stephens upped their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Finally, Royal Bank of Canada reduced their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Two research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $626.79.

UnitedHealth Group Stock Up 4.4 %

UnitedHealth Group stock traded up $23.17 during mid-day trading on Monday, reaching $543.86. The stock had a trading volume of 4,259,962 shares, compared to its average volume of 4,190,717. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock’s 50-day simple moving average is $555.25 and its 200-day simple moving average is $562.50. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The firm has a market capitalization of $500.51 billion, a PE ratio of 35.43, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same period last year, the firm earned $6.56 earnings per share. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.54%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.